Invention Grant
- Patent Title: Anti-CD38 antibodies and methods of use
-
Application No.: US17503038Application Date: 2021-10-15
-
Publication No.: US11365261B2Publication Date: 2022-06-21
- Inventor: Béatrice Cameron , Tarik Dabdoubi , Cendrine Lemoine , Catherine Prades
- Applicant: Sanofi
- Applicant Address: FR Paris
- Assignee: Sanofi
- Current Assignee: Sanofi
- Current Assignee Address: FR Paris
- Agency: Morrison & Foerster LLP
- Priority: EP18187186 20180803
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61K45/06 ; A61P35/02 ; C07K16/00 ; A61P35/00 ; A61K39/00

Abstract:
The disclosure provides binding proteins that bind CD38 polypeptides, e.g., human and cynomolgus monkey CD38 polypeptides. For example, the binding proteins can be monospecific, bispecific, or trispecific binding proteins with at least one antigen binding domain that binds a CD38 polypeptide. The disclosure also provides methods for making binding proteins that bind CD38 polypeptides and uses of such binding proteins.
Information query